Holen Sie sich die Stockscreener-App
2.55
4.94%
0.12
Handel nachbörslich:
2.55
Schlusskurs vom Vortag:
$2.43
Offen:
$2.46
24-Stunden-Volumen:
146.47K
Relative Volume:
0.89
Marktkapitalisierung:
$78.53M
Einnahmen:
$1.82M
Nettoeinkommen (Verlust:
$-267.63M
KGV:
-0.1265
EPS:
-20.1639
Netto-Cashflow:
$-50.53M
1W Leistung:
-3.04%
1M Leistung:
-1.16%
6M Leistung:
-74.68%
1J Leistung:
-85.08%
1-Tages-Spanne:
$2.40
$2.62
1-Wochen-Bereich:
$2.31
$2.62
52-Wochen-Spanne:
$2.165
$23.18
Cibus Inc Stock (CBUS) Company Profile
Firmenname
Cibus Inc
Sektor
Branche
Telefon
(858) 450-0008
Adresse
6455 NANCY RIDGE DRIVE, SAN DIEGO
Vergleichen Sie CBUS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CBUS
Cibus Inc
|
2.55 | 78.53M | 1.82M | -267.63M | -50.53M | -20.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
438.40 | 112.90B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
683.08 | 75.06B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
665.68 | 40.45B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
277.16 | 35.75B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
120.88 | 28.98B | 3.30B | -501.07M | 1.03B | -2.1146 |
Cibus Inc Stock (CBUS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-29 | Eingeleitet | Alliance Global Partners | Buy |
| 2024-07-19 | Fortgesetzt | Canaccord Genuity | Buy |
| 2023-10-09 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-07-19 | Fortgesetzt | Canaccord Genuity | Buy |
Cibus Inc Aktie (CBUS) Neueste Nachrichten
Cibus director Gerhard Prante sells $2,725 in stock - MSN
Cibus director Gerhard Prante sells $2,806 in stock - Investing.com
Totus Medicines Appoints Simon Harnest, MSc, BSc, as Chief Financial Officer - GlobeNewswire Inc.
Cibus director Gerhard Prante sells $2,990 in stock - MSN
Cibus director Gerhard Prante sells $2,990 in stock By Investing.com - Investing.com Australia
Cibus director Gerhard Prante sells $5,531 in stock - MSN
Cibus director Gerhard Prante sells $2,978 in stock By Investing.com - Investing.com Canada
Cibus director Gerhard Prante sells $2,978 in stock - MSN
Cibus director Gerhard Prante sells $5,531 in stock By Investing.com - Investing.com South Africa
Cibus’ Agriculture Breeding Breakthroughs Create New Industry Paradigms for Development and Commercialization of Plant Traits - CropLife
Cibus director Prante Gerhard sells $2,875 in stock By Investing.com - Investing.com Australia
Cibus director Prante Gerhard sells $2,875 in stock - MSN
Cibus Co-Founders to Present at Sidoti Micro Cap Conference: Spotlight on Gene Editing Innovation - StockTitan
Cibus to Participate in the Sidoti Micro Cap Conference - The Manila Times
Cibus (NASDAQ:CBUS) Given New $18.00 Price Target at Canaccord Genuity Group - MarketBeat
Canaccord cuts Cibus stock target to $18, maintains buy rating - MSN
Canaccord cuts Cibus stock target to $18, maintains buy rating By Investing.com - Investing.com UK
Cibus Raises $22.6M in Direct Offering, CEO Joins Investment Round at $2.50 Per Share - StockTitan
Cibus director Gerhard Prante sells shares worth $6,106 - MSN
Cibus director Gerhard Prante sells shares worth $6,106 By Investing.com - Investing.com South Africa
Cibus director Gerhard Prante sells $2,783 in stock By Investing.com - Investing.com Australia
Cibus' Agriculture Breeding Breakthroughs Create New Industry Paradigms for Development and Commercialization of Plant Traits - The Manila Times
Cibus director Gerhard Prante sells $2,783 in stock - Investing.com
Cibus director Gerhard Prante sells $2,691 in stock By Investing.com - Investing.com South Africa
Cibus director Gerhard Prante sells $2,691 in stock - Investing.com
Cibus director Gerhard Prante sells $5,911 in stock By Investing.com - Investing.com Australia
Cibus director Gerhard Prante sells $5,911 in stock - Investing.com India
Cibus director Gerhard Prante sells $3,220 in stock By Investing.com - Investing.com Australia
Cibus stock plunges to 52-week low, hits $2.33 amid market challenges - Investing.com Canada
Cibus stock plunges to 52-week low, hits $2.33 amid market challenges By Investing.com - Investing.com South Africa
Finanzdaten der Cibus Inc-Aktie (CBUS)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.49%
0.79%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):